Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam on Microcirculation in Septic Shock
NCT03434691Unknown
- Sponsor
- Military Hospital of Tunis
- Start
- Feb 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in septic shock (2 arms), sponsored by Military Hospital of Tunis. Primary endpoints: Concentration of glucose in the extracellular fluid of the skeletal muscle, Concentration of lactate in the extracellular fluid of the skeletal muscle and 2 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03434691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434691.